Aligos Therapeutics Inc. (ALGS) at a glance

Aligos Therapeutics Inc. (ALGS) is a micro-cap Healthcare company. It trades at $5.46, with a 0% profit margin and revenue growth of 810%. It does not pay a dividend. Vestovix scores it 57/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Momentum (18/100).

Price
$5.47
Market cap
$32.7M
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$4.80 to $13.69
Vestovix Score57/ 100How this works
Value
58
Growth
94
Income
40
Safety
46
Momentum
18

Other Healthcare stocks

See all